Harald Holte

23PUBLICATIONS
111CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Apr 22, 2026
A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas.

|Nov 18, 2025
Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma.

Richard T Maziarz, Michael R Bishop, Constantine S Tam

|Sep 08, 2025
Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma.

Lorenzo Falchi, Anna Sureda, Sirpa Leppä

|Jul 17, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Brett Collinge, Laura K Hilton, Jasper Wong

|May 13, 2025
Biomarker-adapted treatment in high-risk large B-cell lymphoma.

Sirpa Leppä, Leo Meriranta, Maare Arffman

|Aug 27, 2024
Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.

Baoyan Bai, Jillian F Wise, Daniel Vodák

Pageof 4

Frequent Collaborators

5 joint publications

Sirpa Leppä

3 joint publications

Lisa Rimsza

3 joint publications

Ingrid Glimelius

3 joint publications

June Helen Myklebust